Clinical applications of TNF-alpha in cancer.

Lejeune, F J; Rüegg, C; Liénard, D

Lejeune, F J; Rüegg, C; Liénard, D.

Affiliation

Lejeune FJ; Centre Pluridisciplinaire d'Oncologie, Centre Hospitalier UniversitaireVaudois (CHUV), Rue du Bugnon 46, CH-1011, Lausanne, Switzerland. Ferdy.Lejeune@chuv.hospvd.ch

Curr Opin Immunol ; 10(5): 573-80, 1998 Oct.

Article in En | MEDLINE | ID: mdl-9794839

Subject(s)

Chemotherapy, Cancer, Regional Perfusion; Neoplasms/therapy; Tumor Necrosis Factor-alpha/administration & dosage; Dose-Response Relationship, Drug; Endothelium, Vascular/physiology; Humans; Interferon-gamma/physiology; Melanoma/therapy; Neoplasms/blood supply; Neoplasms/immunology; Neovascularization, Pathologic/prevention & control; Sarcoma/therapy

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Chemotherapy, Cancer, Regional Perfusion / Tumor Necrosis Factor-alpha / Neoplasms Limits: Humans Language: En Journal: Curr Opin Immunol Journal subject: ALERGIA E IMUNOLOGIA Year: 1998 Document type: Article Affiliation country: Switzerland Country of publication: United kingdom

Search on Google

Add to My VHL

XML

PubMed Links